ROLE OF MESENCHYMAL STEM CELLS ISOLATED FROM DENTAL PULP (HDPSCS) IN IMMUNOMODULATION PROCESSES MEDIATED BY PROGRAMMED DEATH-LIGAND 1 (PD-L1) AND INTERLEUKIN 6 (IL-6)

被引：0
|
作者：
Di Tinco, R. [1 ]
Bertani, G. [1 ]
Pisciotta, A. [1 ]
Bertoni, L. [1 ]
Pignatti, E. [1 ]
Maccaferri, M. [1 ]
Salvarani, C. [1 ]
Carnevale, G. [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Surg Med & Dent Dept Morphol Sci Related Transpla, Modena, Italy
来源：
CYTOTHERAPY | 2021年 / 23卷 / 05期
关键词：
human Dental Pulp Stem Cells; Programmed Death-Ligand 1; Immunomodulation;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
153
引用
收藏
页码：S57 / S58
页数：2
相关论文
共 50 条
  • [1] ROLE OF MESENCHYMAL STEM CELLS ISOLATED FROM DENTAL PULP (DPSCS) IN IMMUNOREGULATION PROCESSES MEDIATED BY PROGRAMMED DEATH-LIGAND 1 (PD-L1)
    Pignatti, E.
    Pisciotta, A.
    Bertani, G.
    Di Tinco, R.
    Bertoni, L.
    Croci, S.
    Bonacini, M.
    Azzoni, P.
    De Pol, A.
    Salvarani, C.
    Carnevale, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1318 - 1318
  • [2] The immunomodulation of osteoblasts and chondroblasts differentiated from programmed death-ligand 1-positive mesenchymal stem cells
    Vu, Ngoc B.
    Dao, Thuy T.
    Truong, Nhat C.
    Nguyen, Hoa T.
    Pham, Phuc, V
    MINERVA BIOTECHNOLOGY AND BIOMOLECULAR RESEARCH, 2021, 33 (04): : 177 - 186
  • [3] Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells
    Rosanna Di Tinco
    Giulia Bertani
    Alessandra Pisciotta
    Laura Bertoni
    Elisa Pignatti
    Monia Maccaferri
    Jessika Bertacchini
    Paola Sena
    Antonio Vallarola
    Rossella Tupler
    Stefania Croci
    Martina Bonacini
    Carlo Salvarani
    Gianluca Carnevale
    Stem Cell Research & Therapy, 12
  • [4] Role of PD-L1 in licensing immunoregulatory function of dental pulp mesenchymal stem cells
    Di Tinco, Rosanna
    Bertani, Giulia
    Pisciotta, Alessandra
    Bertoni, Laura
    Pignatti, Elisa
    Maccaferri, Monia
    Bertacchini, Jessika
    Sena, Paola
    Vallarola, Antonio
    Tupler, Rossella
    Croci, Stefania
    Bonacini, Martina
    Salvarani, Carlo
    Carnevale, Gianluca
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [5] Programmed death-ligand 1 (PD-L1) may play a role in malignant glioma infiltration
    Zhang, Lei
    Zhang, Zhiqing
    Liu, Yunhui
    Xue, Yixue
    Parney, Ian
    MEDICAL HYPOTHESES, 2015, 85 (02) : 127 - 129
  • [6] Unexpected role of programmed death-ligand 1 (PD-L1) in renal allografts with antibody-mediated rejection.
    Ozdemir, B. Handan
    Basturk, Bilkay
    Terzi, Aysen
    Sayin, C. Burak
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (9S)
  • [7] Unexpected role of programmed death-ligand 1 (PD-L1) in renal allografts with antibody-mediated rejection.
    Ozdemir, B. Handan
    Basturk, Bilkay
    Terzi, Aysen
    Sayin, C. Burak
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (09) : 135 - 135
  • [8] The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer
    Hsu, Ping-Chih
    Yang, Cheng-Ta
    Jablons, David M.
    You, Liang
    BIOMEDICINES, 2018, 6 (04)
  • [9] PROGRAMMED CELL DEATH-LIGAND 1 (PD-L1) IS NOT EXPRESSED IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TUMOR CELLS
    Walia, Preet
    D'Arcy, Colleen
    Hawkins, Cynthia
    Warren, Katherine E.
    NEURO-ONCOLOGY, 2018, 20 : 126 - 126
  • [10] Expression of Programmed Death-Ligand 1 and 2 (PD-L1/2) on Tumor cells of Oropharyngeal Squamous Cell Carcinoma (OPSCC)
    Wuerdemann, N.
    Gueltekin, S. E.
    Wittekindt, C.
    Sharma, S. J.
    Schubotz, A. B.
    Gattenloehner, S.
    Tharun, L.
    Baris, E.
    Sengueven, B.
    Yildirim, B.
    Buettner, R.
    Speel, E. -J.
    Wagner, S.
    Klussmann, J. -P.
    Quaas, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 95 - 95
12345